MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2018Read more
New data from the MIV-711 phase II program will be presented at the ACR Annual Meeting on October 21Read more
Medivir scales back research costs to focus on clinical developmentRead more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.